Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease
Diabetes Care - United States
doi 10.2337/dc16-0173
Full Text
Open PDFAbstract
Available in full text
Date
January 13, 2017
Authors
Publisher
American Diabetes Association